| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 8 | 2023 | 73 | 4.080 |
Why?
|
| Pregnancy | 48 | 2024 | 1484 | 3.940 |
Why?
|
| Depression | 9 | 2023 | 512 | 3.580 |
Why?
|
| Female | 64 | 2024 | 12838 | 2.240 |
Why?
|
| Premature Birth | 8 | 2023 | 135 | 2.230 |
Why?
|
| Anxiety | 5 | 2023 | 153 | 2.080 |
Why?
|
| Depression, Postpartum | 3 | 2023 | 16 | 2.020 |
Why?
|
| Pregnancy Complications | 6 | 2020 | 193 | 1.990 |
Why?
|
| Humans | 65 | 2024 | 18058 | 1.890 |
Why?
|
| Alcohol Drinking | 9 | 2020 | 375 | 1.850 |
Why?
|
| Pregnant Women | 3 | 2023 | 44 | 1.760 |
Why?
|
| Adult | 45 | 2024 | 7696 | 1.750 |
Why?
|
| Pregnancy Complications, Infectious | 6 | 2022 | 139 | 1.650 |
Why?
|
| Hallucinogens | 2 | 2022 | 23 | 1.610 |
Why?
|
| California | 19 | 2024 | 2327 | 1.530 |
Why?
|
| Intimate Partner Violence | 2 | 2023 | 12 | 1.480 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2023 | 144 | 1.330 |
Why?
|
| Pandemics | 8 | 2023 | 293 | 1.310 |
Why?
|
| Prenatal Care | 5 | 2024 | 136 | 1.240 |
Why?
|
| Abortion, Spontaneous | 3 | 2014 | 51 | 1.210 |
Why?
|
| Perinatal Care | 2 | 2016 | 12 | 1.110 |
Why?
|
| Substance-Related Disorders | 6 | 2022 | 439 | 1.100 |
Why?
|
| Pregnancy Outcome | 5 | 2023 | 158 | 1.020 |
Why?
|
| Anxiety Disorders | 4 | 2023 | 91 | 0.990 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 1309 | 0.950 |
Why?
|
| Overweight | 2 | 2022 | 272 | 0.910 |
Why?
|
| Postpartum Period | 1 | 2024 | 93 | 0.910 |
Why?
|
| Influenza, Human | 4 | 2020 | 277 | 0.850 |
Why?
|
| Vitamins | 4 | 2022 | 66 | 0.850 |
Why?
|
| Adolescent | 17 | 2023 | 3714 | 0.850 |
Why?
|
| Pre-Eclampsia | 3 | 2023 | 38 | 0.850 |
Why?
|
| Stress, Psychological | 4 | 2022 | 145 | 0.840 |
Why?
|
| Autistic Disorder | 1 | 2023 | 104 | 0.830 |
Why?
|
| Influenza Vaccines | 4 | 2020 | 284 | 0.790 |
Why?
|
| Young Adult | 14 | 2020 | 2479 | 0.790 |
Why?
|
| Marijuana Abuse | 1 | 2021 | 39 | 0.770 |
Why?
|
| Legislation, Drug | 1 | 2021 | 8 | 0.770 |
Why?
|
| Dietary Supplements | 3 | 2014 | 91 | 0.760 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 155 | 0.750 |
Why?
|
| Marijuana Use | 1 | 2021 | 25 | 0.750 |
Why?
|
| Alcoholism | 7 | 2009 | 346 | 0.740 |
Why?
|
| Temperature | 2 | 2017 | 18 | 0.730 |
Why?
|
| Child Development | 1 | 2020 | 49 | 0.700 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 49 | 0.690 |
Why?
|
| Health Plan Implementation | 2 | 2016 | 42 | 0.670 |
Why?
|
| Cohort Studies | 12 | 2024 | 2631 | 0.670 |
Why?
|
| Spouse Abuse | 1 | 2017 | 9 | 0.610 |
Why?
|
| Depressive Disorder | 1 | 2020 | 233 | 0.610 |
Why?
|
| Diet | 1 | 2020 | 359 | 0.610 |
Why?
|
| Alcoholics Anonymous | 4 | 2011 | 14 | 0.590 |
Why?
|
| Risk-Taking | 2 | 2009 | 113 | 0.560 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2016 | 248 | 0.550 |
Why?
|
| Infant, Newborn | 11 | 2023 | 852 | 0.540 |
Why?
|
| Temperance | 3 | 2012 | 25 | 0.520 |
Why?
|
| Health | 2 | 2015 | 35 | 0.520 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2015 | 9 | 0.510 |
Why?
|
| Computers | 1 | 2014 | 7 | 0.510 |
Why?
|
| Dietary Carbohydrates | 1 | 2014 | 27 | 0.510 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2015 | 28 | 0.500 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 14 | 0.500 |
Why?
|
| Beer | 1 | 2014 | 9 | 0.490 |
Why?
|
| Wine | 1 | 2014 | 18 | 0.480 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 39 | 0.480 |
Why?
|
| Antiviral Agents | 2 | 2014 | 96 | 0.480 |
Why?
|
| Aging | 2 | 2015 | 159 | 0.470 |
Why?
|
| Male | 17 | 2023 | 10173 | 0.470 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2014 | 22 | 0.470 |
Why?
|
| United States | 13 | 2023 | 4119 | 0.440 |
Why?
|
| Counseling | 1 | 2014 | 199 | 0.440 |
Why?
|
| Child | 8 | 2023 | 2519 | 0.430 |
Why?
|
| Life Tables | 1 | 2012 | 11 | 0.420 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2011 | 5 | 0.410 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 445 | 0.400 |
Why?
|
| Retrospective Studies | 8 | 2022 | 2498 | 0.400 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2011 | 56 | 0.400 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2011 | 75 | 0.390 |
Why?
|
| Risk Factors | 7 | 2023 | 3394 | 0.380 |
Why?
|
| Social Support | 3 | 2011 | 211 | 0.380 |
Why?
|
| Surveys and Questionnaires | 8 | 2017 | 1346 | 0.380 |
Why?
|
| African Continental Ancestry Group | 1 | 2011 | 165 | 0.380 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 41 | 0.370 |
Why?
|
| Community Mental Health Services | 2 | 2008 | 33 | 0.370 |
Why?
|
| Social Environment | 2 | 2008 | 93 | 0.360 |
Why?
|
| Patient Compliance | 2 | 2009 | 303 | 0.350 |
Why?
|
| Mass Screening | 1 | 2014 | 678 | 0.330 |
Why?
|
| European Continental Ancestry Group | 1 | 2011 | 559 | 0.330 |
Why?
|
| Middle Aged | 12 | 2021 | 8073 | 0.320 |
Why?
|
| Psychometrics | 3 | 2023 | 120 | 0.320 |
Why?
|
| Interpersonal Relations | 2 | 2008 | 41 | 0.320 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 77 | 0.320 |
Why?
|
| Body Mass Index | 3 | 2022 | 961 | 0.320 |
Why?
|
| Sexual Behavior | 1 | 2009 | 123 | 0.310 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 705 | 0.300 |
Why?
|
| Exercise | 2 | 2022 | 478 | 0.290 |
Why?
|
| Seasons | 2 | 2017 | 99 | 0.290 |
Why?
|
| Maternal Health Services | 2 | 2016 | 12 | 0.280 |
Why?
|
| Risk Assessment | 4 | 2020 | 1137 | 0.270 |
Why?
|
| Hispanic Americans | 2 | 2020 | 431 | 0.270 |
Why?
|
| Prevalence | 6 | 2014 | 892 | 0.270 |
Why?
|
| Genotyping Techniques | 1 | 2015 | 26 | 0.260 |
Why?
|
| Computational Biology | 1 | 2015 | 28 | 0.260 |
Why?
|
| Maternal Age | 2 | 2017 | 79 | 0.260 |
Why?
|
| Adaptation, Psychological | 2 | 2022 | 82 | 0.260 |
Why?
|
| Genomics | 1 | 2015 | 65 | 0.250 |
Why?
|
| Self-Help Groups | 1 | 2004 | 32 | 0.240 |
Why?
|
| Marital Status | 1 | 2004 | 22 | 0.240 |
Why?
|
| Social Segregation | 1 | 2023 | 2 | 0.240 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 324 | 0.240 |
Why?
|
| Smoking | 3 | 2017 | 465 | 0.230 |
Why?
|
| Infant | 4 | 2022 | 1212 | 0.230 |
Why?
|
| Prospective Studies | 4 | 2020 | 1294 | 0.230 |
Why?
|
| Eclampsia | 1 | 2023 | 12 | 0.230 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2023 | 5 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2015 | 397 | 0.230 |
Why?
|
| Continental Population Groups | 1 | 2015 | 317 | 0.220 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2022 | 8 | 0.220 |
Why?
|
| Folic Acid | 1 | 2022 | 35 | 0.220 |
Why?
|
| Analgesics | 1 | 2022 | 28 | 0.220 |
Why?
|
| Central Nervous System Stimulants | 1 | 2022 | 29 | 0.210 |
Why?
|
| Labetalol | 1 | 2022 | 9 | 0.210 |
Why?
|
| Drug Utilization | 2 | 2013 | 134 | 0.210 |
Why?
|
| Primary Health Care | 1 | 2009 | 843 | 0.210 |
Why?
|
| Socioeconomic Factors | 5 | 2017 | 667 | 0.210 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 34 | 0.210 |
Why?
|
| Cannabinoids | 1 | 2021 | 5 | 0.210 |
Why?
|
| Ethnic Groups | 1 | 2015 | 504 | 0.200 |
Why?
|
| Calcineurin Inhibitors | 1 | 2020 | 2 | 0.190 |
Why?
|
| Glucocorticoids | 1 | 2020 | 15 | 0.190 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 80 | 0.190 |
Why?
|
| Dermatitis, Atopic | 1 | 2020 | 13 | 0.190 |
Why?
|
| Triglycerides | 1 | 2021 | 86 | 0.190 |
Why?
|
| Mental Health | 1 | 2022 | 166 | 0.190 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2020 | 24 | 0.180 |
Why?
|
| Gestational Age | 3 | 2023 | 119 | 0.180 |
Why?
|
| Self Medication | 1 | 2020 | 5 | 0.180 |
Why?
|
| Psychological Trauma | 1 | 2020 | 6 | 0.180 |
Why?
|
| Ideal Body Weight | 1 | 2020 | 10 | 0.180 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 9 | 0.180 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 55 | 0.180 |
Why?
|
| Fruit | 1 | 2020 | 72 | 0.180 |
Why?
|
| Vegetables | 1 | 2020 | 80 | 0.180 |
Why?
|
| Vaccines, Inactivated | 1 | 2020 | 70 | 0.180 |
Why?
|
| Ethanol | 2 | 2023 | 22 | 0.180 |
Why?
|
| Energy Intake | 1 | 2020 | 100 | 0.180 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 28 | 0.180 |
Why?
|
| Time Factors | 2 | 2014 | 1114 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 64 | 0.170 |
Why?
|
| Obesity | 2 | 2022 | 839 | 0.170 |
Why?
|
| Pediatric Obesity | 1 | 2020 | 75 | 0.170 |
Why?
|
| HIV Infections | 1 | 2005 | 682 | 0.160 |
Why?
|
| Women's Health | 2 | 2021 | 208 | 0.160 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 1255 | 0.160 |
Why?
|
| Treatment Outcome | 4 | 2013 | 1259 | 0.150 |
Why?
|
| Weather | 1 | 2017 | 2 | 0.150 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 42 | 0.150 |
Why?
|
| Pregnancy Trimesters | 1 | 2016 | 29 | 0.140 |
Why?
|
| Drug Prescriptions | 2 | 2020 | 157 | 0.140 |
Why?
|
| Maternal Exposure | 1 | 2016 | 54 | 0.140 |
Why?
|
| Risk | 2 | 2014 | 552 | 0.130 |
Why?
|
| Molecular Epidemiology | 2 | 2015 | 44 | 0.130 |
Why?
|
| Medicaid | 1 | 2017 | 206 | 0.130 |
Why?
|
| Breast Feeding | 1 | 2017 | 134 | 0.130 |
Why?
|
| Data Collection | 2 | 2007 | 276 | 0.130 |
Why?
|
| Hypertension | 1 | 2020 | 489 | 0.130 |
Why?
|
| Population Surveillance | 2 | 2014 | 270 | 0.130 |
Why?
|
| Herpes Genitalis | 1 | 2014 | 4 | 0.130 |
Why?
|
| Labor, Induced | 1 | 2014 | 6 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2016 | 330 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2014 | 116 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2014 | 73 | 0.120 |
Why?
|
| Medical Records | 1 | 2014 | 108 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2020 | 734 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2014 | 235 | 0.120 |
Why?
|
| Health Behavior | 2 | 2014 | 379 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 81 | 0.120 |
Why?
|
| African Americans | 1 | 2017 | 485 | 0.110 |
Why?
|
| Insurance Coverage | 1 | 2014 | 136 | 0.110 |
Why?
|
| Preventive Health Services | 1 | 2014 | 164 | 0.110 |
Why?
|
| Anticonvulsants | 1 | 2012 | 10 | 0.110 |
Why?
|
| Epilepsy | 1 | 2012 | 13 | 0.110 |
Why?
|
| Prescriptions | 1 | 2013 | 28 | 0.110 |
Why?
|
| Educational Status | 3 | 2023 | 205 | 0.110 |
Why?
|
| Schizophrenia | 1 | 2013 | 80 | 0.110 |
Why?
|
| Abortion, Induced | 1 | 2012 | 16 | 0.110 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 6 | 0.110 |
Why?
|
| Antipsychotic Agents | 1 | 2013 | 57 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2013 | 129 | 0.100 |
Why?
|
| Mothers | 2 | 2022 | 110 | 0.090 |
Why?
|
| Vaccination | 1 | 2015 | 664 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 289 | 0.090 |
Why?
|
| Antihypertensive Agents | 2 | 2022 | 170 | 0.090 |
Why?
|
| South Africa | 1 | 2009 | 17 | 0.080 |
Why?
|
| Tobacco | 2 | 2023 | 15 | 0.080 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 338 | 0.080 |
Why?
|
| Helping Behavior | 1 | 2007 | 2 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2020 | 1428 | 0.070 |
Why?
|
| Logistic Models | 3 | 2017 | 953 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 454 | 0.070 |
Why?
|
| Day Care, Medical | 1 | 2005 | 2 | 0.070 |
Why?
|
| Sex Factors | 1 | 2008 | 634 | 0.070 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 23 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 24 | 0.070 |
Why?
|
| Quality Control | 1 | 2015 | 45 | 0.070 |
Why?
|
| Pedigree | 1 | 2015 | 55 | 0.070 |
Why?
|
| Demography | 1 | 2005 | 106 | 0.060 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2005 | 106 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 595 | 0.060 |
Why?
|
| Probability | 1 | 2004 | 86 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 328 | 0.060 |
Why?
|
| Censuses | 1 | 2023 | 32 | 0.060 |
Why?
|
| Aged | 3 | 2020 | 6258 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 407 | 0.060 |
Why?
|
| Motivation | 1 | 2004 | 133 | 0.060 |
Why?
|
| Stillbirth | 1 | 2023 | 30 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 11 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 394 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2005 | 166 | 0.050 |
Why?
|
| Accelerometry | 1 | 2022 | 37 | 0.050 |
Why?
|
| Nicotine | 1 | 2022 | 46 | 0.050 |
Why?
|
| Methyldopa | 1 | 2022 | 6 | 0.050 |
Why?
|
| Nifedipine | 1 | 2022 | 7 | 0.050 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 552 | 0.050 |
Why?
|
| Sleep | 1 | 2022 | 56 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2020 | 4 | 0.050 |
Why?
|
| Menopause | 1 | 2021 | 72 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 124 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 238 | 0.050 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2020 | 113 | 0.040 |
Why?
|
| Weight Gain | 1 | 2020 | 180 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2012 | 236 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 813 | 0.040 |
Why?
|
| Environment | 1 | 2016 | 52 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1297 | 0.040 |
Why?
|
| Obstetric Labor Complications | 1 | 2014 | 14 | 0.030 |
Why?
|
| Preconception Care | 1 | 2014 | 45 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 2016 | 356 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 393 | 0.030 |
Why?
|
| Oregon | 1 | 2013 | 195 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2013 | 16 | 0.030 |
Why?
|
| Infertility, Female | 1 | 2013 | 11 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2013 | 26 | 0.030 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 19 | 0.030 |
Why?
|
| Binge Drinking | 1 | 2012 | 8 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2014 | 205 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 87 | 0.030 |
Why?
|
| Metformin | 1 | 2013 | 60 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 393 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2013 | 252 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1164 | 0.020 |
Why?
|
| Antisocial Personality Disorder | 1 | 2006 | 3 | 0.020 |
Why?
|
| Marriage | 1 | 2006 | 7 | 0.020 |
Why?
|
| Military Personnel | 1 | 2006 | 12 | 0.020 |
Why?
|
| Behavior | 1 | 2006 | 18 | 0.020 |
Why?
|
| Aggression | 1 | 2006 | 19 | 0.020 |
Why?
|
| Episode of Care | 1 | 2005 | 14 | 0.020 |
Why?
|
| Aftercare | 1 | 2005 | 49 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 70 | 0.020 |
Why?
|
| Family | 1 | 2006 | 119 | 0.020 |
Why?
|
| Recurrence | 1 | 2005 | 186 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2005 | 130 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 264 | 0.020 |
Why?
|
| Parents | 1 | 2006 | 308 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 316 | 0.010 |
Why?
|